iNKT Cells Suppress Pathogenic NK1.1CD8 T Cells in DSS-Induced Colitis.

Lee SW, Park HJ, Cheon JH, Wu L, Van Kaer L, Hong S
Front Immunol. 2018 9: 2168

PMID: 30333822 · PMCID: PMC6176072 · DOI:10.3389/fimmu.2018.02168

T cells producing IFNγ play a pathogenic role in the development of inflammatory bowel disease (IBD). To investigate the functions of CD1d-dependent invariant natural killer T (iNKT) cells in experimental colitis induced in Yeti mice with dysregulated expression of IFNγ, we generated iNKT cell-deficient Yeti/CD1d KO mice and compared colitis among WT, CD1d KO, Yeti, and Yeti/CD1d KO mice following DSS treatment. We found that deficiency of iNKT cells exacerbated colitis and disease pathogenesis was mainly mediated by NK1.1CD8 T cells. Furthermore, the protective effects of iNKT cells correlated with up-regulation of regulatory T cells. Taken together, our results have demonstrated that CD1d-dependent iNKT cells and CD1d-independent NK1.1CD8 T cells reciprocally regulate the development of intestinal inflammatory responses mediated by IFNγ-dysregulation. These findings also identify NK1.1CD8 T cells as novel target cells for the development of therapeutics for human IBD.

MeSH Terms (10)

Animals CD8-Positive T-Lymphocytes Colitis Dextran Sulfate Humans Interferon-gamma Mice Mice, Knockout Natural Killer T-Cells T-Lymphocytes, Regulatory

Connections (1)

This publication is referenced by other Labnodes entities: